AVGO vs PHG Stock Comparison
PHG currently leads AVGO in this stock comparison, with AIQ scores of 72 vs 55. The clearest difference is value.
What is the main difference between AVGO and PHG?
PHG leads the current stock comparison as Koninklijke Philips N.V., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Broadcom Inc. vs Koninklijke Philips N.V.
PHG leads
PHG leads by 17 AIQ points, primarily on Value and Risk Resilience, and the lead has widened from 9 points over 30 sessions.
Stable: 4 of 5 evidence groups support PHG, its lead is widening, and its current signal state is conflicted.
Broadcom Inc.
Koninklijke Philips N.V.
The Algovestiq AIQ Score currently favors PHG over AVGO, 72 versus 55 as of Nov 18, 2026. PHG's advantage is driven primarily by stronger value and risk resilience. PHG also shows the stronger technical structure relative to its 50-day moving average. 4 of 5 covered evidence groups favor PHG today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. PHG lead: Strengthening — the AIQ differential moved from 9 to 17 points over 30 sessions.
Compare Broadcom Inc. and Koninklijke Philips N.V. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AVGO and PHG against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value48 vs 80PHG +32
- Risk Resilience48 vs 73PHG +25
- Momentum49 vs 72PHG +23
- Quality69 vs 67Even
4 of 5 evidence groups favor PHG. PHG’s edge is concentrated in value and risk resilience.
What changed since the last close
Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.
Largest factor move: Momentum +2
No signal started or stopped since the prior session; its 6 active signals are unchanged.
Largest factor move: Value +1, not enough on its own to move the overall score.
New signals
- RSI Overbought — bearish, momentum, short horizon
PHG's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — AVGO and PHG both carry a full feed there.
The central trade-off
PHG (Koninklijke Philips N.V.): the stronger current systematic profile, led by value and risk resilience.
AVGO (Broadcom Inc.): the counter-case, on fundamentals — but at materially higher volatility, 70% against 38.9%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
PHGPHG on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AVGOAVGO on combined revenue and EPS growth.
Value
PHGPHG on the peer-relative Value factor, by 32 points.
Momentum
PHGPHG on the Momentum factor, by 23 points.
Lower downside
PHGPHG on Risk Resilience, by 25 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AVGO | PHG | Note |
|---|---|---|---|
| Implied upside to target | +45.5% | — | Level |
| Target dispersion | +48.5% | — | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 51 | 5 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 5 covered evidence groups favor PHG. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | PHG | 55 vs 72 |
| Fundamentals | AVGO | EPS growth 40.3% vs -93.1%; gross margin 68.8% vs 46.4%; operating margin 48% vs 10.9% |
| Valuation | PHG | Value 48 vs 80 |
| Technicals | PHG | Price vs 50-day 2.5% vs 14%; vs 200-day -5.6% vs 11.4% |
| Risk Resilience | PHG | Risk Resilience 48 vs 73 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and PHG and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 17 points. (supports the conclusion holding)
- 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PHG.
How the comparison changed
120 daily snapshots · Jun 1 – Nov 18PHG lead: Strengthening — the AIQ differential moved from 9 to 17 points over 30 sessions.
- Today
- PHG +17
- 55 vs 72
- 7 sessions ago
- PHG +20
- 53 vs 73
- 30 sessions ago
- PHG +9
- 54 vs 63
- 90 sessions ago
- PHG +3
- 57 vs 60
The lead changed hands once in this window, most recently on Aug 12 when AVGO moved ahead of PHG.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish / 2 neutral, conflicted
Only AVGO
- ADX Trend Weakening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.14%)
- Accumulation Pattern — bullish, volume, medium horizon (1.18x)
- Beta Spike Warning — bearish, risk_regime, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
3 bullish / 2 bearish / 1 neutral, conflicted
Only PHG
- ADX Trend Strengthening — neutral, trend, medium horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- RSI Overbought — bearish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
Both carry 1 more signal that do not separate them: Death Cross Active.
PHG leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +3.64%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.27%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AVGO closes the Value gap — currently 32 points behind, the largest single contributor to PHG's edge.
- 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AVGO leads on balance| Metric | AVGO | PHG |
|---|---|---|
| Revenue growth (YoY) | 33.4% | 0.2% |
| EPS growth (YoY) | 40.3% | -93.1% |
| Gross margin | 68.8% | 46.4% |
| Operating margin | 48% | 10.9% |
| Return on equity (TTM) | 13.1% | 0.2% |
| Debt to equity | 0.6 | 0.7 |
Performance
PHG leads 5 of 6 windows| Metric | AVGO | PHG |
|---|---|---|
| 1 week (5 sessions) | 18.2% | 0% |
| 1 month (20 sessions) | 5.6% | 17.9% |
| 3 months (63 sessions) | -11.6% | 13.1% |
| 6 months (126 sessions) | -18.4% | 20.3% |
| Year to date | 0.3% | 12% |
| 1 year (252 sessions) | -2.3% | 3.3% |
Technicals
PHG has the stronger structure| Metric | AVGO | PHG |
|---|---|---|
| RSI (14) | 53.2 | 70.9 |
| ADX (14) | 23 | 43.2 |
| Price vs 50-day | 2.5% | 14% |
| Price vs 200-day | -5.6% | 11.4% |
| Volatility (1M, annualized) | 70% | 38.9% |
Risk
PHG is the more resilient| Metric | AVGO | PHG |
|---|---|---|
| Beta | 2.21 | 0.85 |
| Sharpe ratio | 0.21 | 0.18 |
| Sortino ratio | 0.29 | 0.27 |
| Max drawdown | -39.5% | -27.7% |
| Current drawdown | -27.9% | -7.8% |
| Annualized volatility | 48.6% | 29.7% |
| Value at risk (95%) | -4.6% | -2.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVGO or PHG?
On the Algovestiq AIQ Score, PHG is the stronger of the two as of Nov 18, 2026, scoring 72 against AVGO's 55. The edge comes from value and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVGO or PHG the better buy right now?
PHG carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Stable — 4 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor PHG over AVGO?
The composite weights Quality, Value, Momentum and Risk Resilience. PHG leads Value by 32 points; PHG leads Risk Resilience by 25 points; PHG leads Momentum by 23 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVGO or PHG?
Analyst price targets imply +45.5% upside for AVGO and not covered for PHG. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVGO or PHG?
PHG is the better-valued of the two on the peer-relative Value factor. PHG on the peer-relative Value factor, by 32 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVGO or PHG?
AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVGO or PHG?
PHG on the Momentum factor, by 23 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVGO or PHG?
PHG is the more resilient of the two, so the other name carries the higher downside risk. PHG on Risk Resilience, by 25 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVGO more profitable than PHG?
AVGO leads on the comparable margin measures — gross margin 68.8% vs 46.4%; operating margin 48% vs 10.9%; ttm roe 13.1% vs 0.2%.
Is PHG's lead over AVGO getting stronger or weaker?
PHG lead: Strengthening — the AIQ differential moved from 9 to 17 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has changed hands once in that window, most recently on 2026-08-12, when AVGO moved ahead of PHG.
What would change the AVGO vs PHG verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Value gap — currently 32 points behind, the largest single contributor to PHG's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about AVGO and PHG?
AVGO: 2 bullish / 2 bearish / 2 neutral, conflicted. PHG: 3 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On PHG it is Death Cross Active (bearish, long horizon).
Compare AVGO and PHG with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.